Self-medication of regular headache: a community pharmacy-based survey
European Journal of Neurology, 04/18/2012Mehuys E et al.
The study identified underdiagnosis of migraine, low use of migraine prophylaxis and triptans, and high prevalence of medication overuse amongst subjects seeking self–medication for regular headache. Community pharmacists have a strategic position in education and referral of these self–medicating headache patients.
Participants (n = 1205) completed (i) a questionnaire to assess current headache medication and previous physician diagnosis, (ii) the ID Migraine Screener (ID–M), and (iii) the Migraine Disability Assessment questionnaire.
Forty–four percentage of the study population (n = 528) did not have a physician diagnosis of their headache, and 225 of them (225/528, 42.6%) were found to be ID–M positive.
The most commonly used acute headache drugs were paracetamol (used by 62% of the study population), NSAIDs (39%), and combination analgesics (36%).
Only 12% of patients physician–diagnosed with migraine used prophylactic migraine medication, and 25% used triptans.
About 24% of the sample (n = 292) chronically overused acute medication, which was combination analgesic overuse (n = 166), simple analgesic overuse (n = 130), triptan overuse (n = 19), ergot overuse (n = 6), and opioid overuse (n = 5).
Only 14.5% was ever advised to limit intake frequency of acute headache treatments.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.